Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456

LaTonya J. Hickson(Jacksonville College), James L. Kirkland(Cedars-Sinai Medical Center), Daniel M. Koerber(Mayo Clinic in Florida), Nino Giorgadze(Mayo Clinic in Florida), Mark Wentworth(Mayo Clinic in Florida), Nathan K. LeBrasseur(WinnMed), Ailing Xue(Mayo Clinic in Florida), Robert J. Pignolo(Mayo Clinic in Arizona), Kyra L. Jordan(WinnMed), Sundeep Khosla(WinnMed), Lilach O. Lerman(Mayo Clinic), Tamar Tchkonia(Cedars-Sinai Medical Center), Qingyi Jia(WinnMed), Elizabeth J. Atkinson(Mayo Clinic in Arizona), Shahrukh K. Hashmi(Mayo Clinic), Ishran M. Saadiq(WinnMed), Tammie L. Volkman(WinnMed), Travis J. McKenzie(Mayo Clinic), Tamara K. Evans(WinnMed), Stella Victorelli(Mayo Clinic in Florida), Keisuke Ejima(Indiana University Bloomington), Kalli K. Schaefer(Mayo Clinic in Florida), David B. Allison(Indiana University Bloomington), Tamar Pirtskhalava(Mayo Clinic in Florida), Shane A. Bobart(WinnMed), Erin O. Wissler Gerdes(University of Iowa), Anthony B. Lagnado(Mayo Clinic), Donna K. Lawson(Mayo Clinic Hospital), Stephanie Dickinson(Indiana University Bloomington), Larissa Prata(Cedars-Sinai Medical Center), Marc E. Lenburg(Boston University), Sandra M. Herrmann(Mayo Clinic), Yi Zhu(University of Macau), Todd A. Kellogg(WinnMed), Kathleen M. McDonald(Mayo Clinic in Florida), Michael D. Jensen(Mayo Clinic), Stephen C. Textor(Textron Systems (United Kingdom)), João F. Passos(Newcastle University)

EBioMedicine

January 23, 2020

Cited by 59

|Journal of the American College of Cardiology|2013|4k

|Circulation|2013|2.7k

|Aging Cell|2015|2.4k

|Nature Communications|2017|1.5k

|EBioMedicine|2019|1.3k

Related Papers